Absence of OcaB protects against age-induced insulin resistance.

Slides:



Advertisements
Similar presentations
Peter J Voshol, PhD Director of Disease Model Core Senior Research Associate: Integrative Physiology Disease Model Core Metabolic Phenotyping: which parameters.
Advertisements

Journal Club 亀田メディカルセンター 糖尿病内分泌内科 Diabetes and Endocrine Department, Kameda Medical Center 松田 昌文 Matsuda, Masafumi 2008 年1月 10 日 8:20-8:50 B 棟8階 カンファレンス室.
From: Effect of a Low-Carbohydrate Diet on Appetite, Blood Glucose Levels, and Insulin Resistance in Obese Patients with Type 2 Diabetes Ann Intern Med.
Choosing a test of glucose metabolism in mice.
Volume 20, Issue 3, Pages (July 2017)
Volume 15, Issue 4, Pages (April 2012)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Impaired glucose tolerance in adult S1/3 KO mice on a normal chow
James F. List, Jean M. Whaley  Kidney International 
Box plot representing the median GIRs (mg/kg/min) by CD300LG genotype during the last 30 min of the HEC. The center lines show the medians; box limits.
Fasting plasma adiponectin concentration in relation to body mass index (BMI) (A), waist circumference (B), acute insulin response (AIR) (C) and insulin.
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 23, Issue 6, Pages (June 2016)
Dandan Wang et al. BTS 2018;3: Diabetes Exacerbates Myocardial Infarction and Ischemia/Reperfusion Injury (A) Comparison of fasting blood glucose.
Volume 24, Issue 8, Pages e7 (August 2018)
Whole-body glucose kinetics in C and T2D-O during postabsorptive and clamp states. Whole-body glucose kinetics in C and T2D-O during postabsorptive and.
Mice with AS160/TBC1D4-Thr649Ala Knockin Mutation Are Glucose Intolerant with Reduced Insulin Sensitivity and Altered GLUT4 Trafficking  Shuai Chen, David.
Fig. 2. Body weight and size analysis of A1/A2-KO mice
Hyperinsulinemic-euglycemic clamps revealed that obese TPL2KO mice have an improved insulin sensitivity compared with obese WT mice. Hyperinsulinemic-euglycemic.
NOx ASR (in mmol/day), arginine Ra (in µmol/kg × min), the fraction of arginine flux converted to NOx (%), and the insulin-mediated glucose disposal (M)
Deletion of neuronal insulin receptor signaling reduces TG secretion, while the targeted knockout of insulin receptors restricted to the periphery increases.
Hyperinsulinemic-euglycemic clamp–derived insulin sensitivity (glucose disposal), model-derived insulin secretion parameters (sensitivity first-phase insulin.
Glucose metabolic index measured using 2-deoxyglucose (2[3H]DG) was measured for the gastrocnemius and superficial vastus lateralis (SVL) during the last.
Exogenous CRP administration causes fasting hyperglycemia and hyperinsulinemia without altering body composition. Exogenous CRP administration causes fasting.
1018-NT-β-cell clusters protect mice from STZ-induced diabetes.
Plasma glucose (A) and glucose specific activity (B) during euglycemic clamp experiments. Plasma glucose (A) and glucose specific activity (B) during euglycemic.
TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin resistance. TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin.
Glucose infusion rate required to maintain the hyperglycemic clamp during the experimental period in sedentary and exercised dogs receiving basal or elevated.
Activation of β-adrenoceptors improves glucose tolerance in diabetic animals and increases glucose uptake in vivo, ex vivo, and in vitro. Activation of.
Volume 4, Issue 5, Pages (November 2006)
A: The change of plasma glucose in opioid μ-receptor knockout diabetic mice and wild-type controls receiving an oral intake of metformin (100 mg/kg). A:
Arterial plasma glucose level and peripheral GIR in conscious dogs during the basal (−40 to 0 min) and experimental (0–240 min) periods treated with vehicle.
Effect of gonadotropin-releasing-hormone-induced hypogonadism on insulin action as assessed by euglycemic clamp studies in men  Subodhsingh Chauhan, M.D.,
Modulation of insulin sensitivity by IL-6 in mice: A lack of PTP1B prevents chronic effects of IL-6. Modulation of insulin sensitivity by IL-6 in mice:
Plasma growth hormone concentrations during a 65-min infusion of acyl ghrelin at 0.3, 0.9, or 1.5 nmol/kg/h, or saline. Plasma growth hormone concentrations.
TXNIP and caspase-1 protein levels are increased in the adipose tissue of ob/ob mice. TXNIP and caspase-1 protein levels are increased in the adipose tissue.
A: The correlation between the GIR and FGU, each measured during the last 40 min of the euglycemic insulin clamp. A: The correlation between the GIR and.
Measurement of insulin release from islets evoked by glucose, diazoxide, and high K+. Measurement of insulin release from islets evoked by glucose, diazoxide,
Glucose tolerance in WT and TRPM2-KO mice.
A: QTL analysis of genotyping data on chromosome 12 revealed a locus linked to glucose levels in F2 mice at 6 months of age at marker D12Mit231 with a.
At 6 months of age, PPARγ deletion in late osteoblast/osteocyte controls glucose homeostasis by increasing metabolic rate and glucose uptake in WAT, BAT,
ΑGLP-1R−/− mice show glucose intolerance and disturbed glucagon secretion in response to i.p. glucose administration. αGLP-1R−/− mice show glucose intolerance.
Insulin sensitivity in athletes and sedentary normal-weight and obese, young, and old individuals. Insulin sensitivity in athletes and sedentary normal-weight.
A: Chemical structure of pterosin A
ATL-801 treatment increases insulin sensitivity in KKAY mice.
Chop deletion preserves β-cell function in P58IPK−/− mice.
Rapid improvement of glucose tolerance induced by PP
Effect of anandamide on blood glucose clearance and insulin sensitivity. Effect of anandamide on blood glucose clearance and insulin sensitivity. A: Intraperitoneal.
Hepatic PPARγ deficiency impairs the SCFA-induced reduction in hepatic steatosis. Hepatic PPARγ deficiency impairs the SCFA-induced reduction in hepatic.
Insulin resistance and hepatic steatosis in ASKO mice.
Effects of Rosi treatment on ASKO mice.
Effects of berberine on in vivo metabolism in two animal models of insulin resistance. Effects of berberine on in vivo metabolism in two animal models.
AKT thr308 phosphorylation related to total AKT2 protein in SOL muscle (m. soleus) (A) and EDL muscle (m. extensor digitorum longus) (D) and AKT ser472.
Energy stores in quadriceps muscles at rest (white bars) and after treadmill exercise (black bars) in WT and HSL KO mice. Energy stores in quadriceps muscles.
Metabolic effects of VSG in GLP-1r KO mice.
GTTs and ITTs. A: GTTs of WT (◇), LepTg (♦), Akita (open circles), and LepTg:Akita (closed circles) mice at 8 and 16 weeks of age. GTTs and ITTs. A: GTTs.
High-fat diet–induced glucose intolerance is prevented in ghrelin knockout (Ghr-KO) mice. High-fat diet–induced glucose intolerance is prevented in ghrelin.
Loss of Phb2 in β-cells induces development of diabetes over a 3-week period in β-Phb2−/− mice. Loss of Phb2 in β-cells induces development of diabetes.
Lack of OcaB impairs age-associated B-lymphocyte accumulation in WAT
β-Cell–specific deletion of Phb2 renders mice diabetic.
Pioglitazone administration acutely inhibits insulin secretion and increases insulin clearance in Wistar rats. Pioglitazone administration acutely inhibits.
Inducible liver-specific insulin receptor knockout (iLIRKO) shows insulin resistance in the liver and extrahepatic tissues. Inducible liver-specific insulin.
Mice lacking Y1 receptor in the hematopoietic compartment remain healthy under normal chow feeding conditions. Mice lacking Y1 receptor in the hematopoietic.
Mean (± SE) plasma glucose concentrations, symptom scores, plasma epinephrine and glucagon concentrations, and relative rCBF (as measured by PET counts)
Spearman rank order correlation between suppression of hepatic glucose production with low insulin infusion and 30-min change in glucose response in women.
Plasma concentration of metabolite M1 (left panel), glucose infusion rate (GIR) to maintain euglycemia (middle panel), and blood glucose concentration.
The use of a glucose analog (18F-deoxyglucose) and positron emission tomography images of the left ventricular wall of the heart of a normal subjects (left).
Volume 16, Issue 3, Pages (September 2012)
Fig. 3. Effects of SFN in mice with diet-induced diabetes.
Insulin secretion (hyperglycemic clamp) (A), insulin sensitivity (hyperinsulinemic-euglycemic clamp) (B), and glucose disposition index (GDI) (C) in adolescents.
Presentation transcript:

Absence of OcaB protects against age-induced insulin resistance. Absence of OcaB protects against age-induced insulin resistance. A and B: Intraperitoneal glucose tolerance test in 2-month-old (A) and 6-month-old (B) OcaB+/+ and OcaB−/− mice (n = 11–13/group). C and D: Insulin tolerance test in 2-month-old (C) and 6-month-old (D) OcaB+/+ and OcaB−/− mice (n = 11–13/group). E–H: Rates of glucose infusion (E), glucose disposal (Rd) (F), glucose appearance (Ra) (G), and glucose uptake (H) in 6-month-old OcaB+/+ and OcaB−/− mice (n = 5–6/group) during a euglycemic-hyperinsulinemic clamp consisting of a 5-μCi bolus of D-[3-3H]glucose given at the beginning, followed by infusion of 0.05 μCi/min during a 90-min tracer equilibration period. The clamp then began with a primed continuous infusion of human insulin (a bolus of 16 mU/kg body weight followed by 4 mU/kg body weight/min). The D-[3-3H]glucose infusion was increased to 0.2 μCi/min for the rest of the 120-min experimental period. Euglycemia was achieved by infusing a 20% dextrose solution as necessary. *P < 0.05; ***P < 0.0001. GIR, glucose infusion rate; KO, knockout (OcaB−/−); WT, wild type (OcaB+/+ littermates). Sophie Carter et al. Diabetes 2018;67:1285-1296 ©2018 by American Diabetes Association